On (b)(6) 2016, abbott point of care was contacted by a customer regarding i-stat crea cartridges that yielded suspected discrepant creatinine result on a (b)(6) male patient with type 2 diabetic in for a ct scan.There were no injuries associated with this event, the patient was treated based on the lab results.There was no repeat on i-stat.There was no additional patient information available at the time of this report.Return product isnot available for investigation.(b)(6).At the time of the event there was no indication of a product malfunction based on the information provided and assessed by apoc, however this mdr is a retrospective filing in response to an observation from an fda inspection conducted may 8th to 12th, 2017 at abbott point of care ((b)(4)).
|